FR2239464A1 - - Google Patents

Info

Publication number
FR2239464A1
FR2239464A1 FR7426475A FR7426475A FR2239464A1 FR 2239464 A1 FR2239464 A1 FR 2239464A1 FR 7426475 A FR7426475 A FR 7426475A FR 7426475 A FR7426475 A FR 7426475A FR 2239464 A1 FR2239464 A1 FR 2239464A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7426475A
Other versions
FR2239464B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CRC Compagnie di Ricerca Chimica SpA
Original Assignee
CRC Compagnie di Ricerca Chimica SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CRC Compagnie di Ricerca Chimica SpA filed Critical CRC Compagnie di Ricerca Chimica SpA
Publication of FR2239464A1 publication Critical patent/FR2239464A1/fr
Application granted granted Critical
Publication of FR2239464B1 publication Critical patent/FR2239464B1/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/181,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/181,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24Oxygen atoms
    • C07D243/28Preparation including building-up the benzodiazepine skeleton from compounds containing no hetero rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7426475A 1973-07-30 1974-07-30 Expired FR2239464B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1105673A CH573928A5 (fr) 1973-07-30 1973-07-30

Publications (2)

Publication Number Publication Date
FR2239464A1 true FR2239464A1 (fr) 1975-02-28
FR2239464B1 FR2239464B1 (fr) 1978-04-14

Family

ID=4369623

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7426475A Expired FR2239464B1 (fr) 1973-07-30 1974-07-30

Country Status (21)

Country Link
US (1) US4010153A (fr)
JP (1) JPS5041886A (fr)
AR (1) AR202224A1 (fr)
AT (1) AT337192B (fr)
BE (1) BE818047A (fr)
CA (1) CA1021778A (fr)
CH (1) CH573928A5 (fr)
DE (1) DE2436744A1 (fr)
DK (1) DK138798B (fr)
ES (1) ES428675A1 (fr)
FI (1) FI227474A (fr)
FR (1) FR2239464B1 (fr)
GB (1) GB1481219A (fr)
HU (1) HU169180B (fr)
IE (1) IE39904B1 (fr)
IL (1) IL45289A (fr)
NL (1) NL7410256A (fr)
NO (1) NO137897C (fr)
SE (2) SE7409708L (fr)
SU (1) SU528872A3 (fr)
ZA (1) ZA744635B (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0167919A2 (fr) * 1984-06-26 1986-01-15 Merck & Co. Inc. Dérivés de benzodiazépine et compositions pharmaceutiques les contenant
EP0284256B1 (fr) * 1987-03-16 1994-06-01 Merck & Co. Inc. Analogues de la benzodiazépine

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3324977T (lt) 2015-07-22 2022-10-25 Enanta Pharmaceuticals, Inc. Benzodiazepino dariniai kaip rsv inhibitoriai
CN108699077B (zh) 2016-01-15 2021-03-02 英安塔制药有限公司 作为rsv抑制剂的杂环化合物
US10358441B2 (en) 2017-02-16 2019-07-23 Enanta Pharmaceuticals, Inc. Processes for the preparation of benzodiazepine derivatives
US10752598B2 (en) 2017-06-07 2020-08-25 Enanta Pharmaceuticals, Inc. Aryldiazepine derivatives as RSV inhibitors
WO2019006295A1 (fr) 2017-06-30 2019-01-03 Enanta Pharmaceuticals, Inc. Composés hétérocycliques utilisés en tant qu'inhibiteurs du vrs
US10851115B2 (en) 2017-06-30 2020-12-01 Enanta Pharmaceuticals, Inc. Heterocyclic compounds as RSV inhibitors
EP3687543B1 (fr) 2017-09-29 2024-03-20 Enanta Pharmaceuticals, Inc. Agents pharmaceutiques en combinaison en tant qu'inhibiteurs de rsv
US10647711B2 (en) 2017-11-13 2020-05-12 Enanta Pharmaceuticals, Inc. Azepin-2-one derivatives as RSV inhibitors
US10501422B2 (en) 2017-11-13 2019-12-10 Enanta Pharmaceuticals, Inc. Processes for the resolution of benzodiazepin-2-one and benzoazepin-2-one derivatives
US10975094B2 (en) 2018-04-11 2021-04-13 Enanta Pharmaceuticals, Inc. Heterocyclic compounds as RSV inhibitors
JP2022525893A (ja) 2019-03-18 2022-05-20 エナンタ ファーマシューティカルズ インコーポレイテッド Rsv阻害剤としてのベンゾジアゼピン誘導体
US11179400B2 (en) 2019-04-09 2021-11-23 Enanta Pharmaceuticals, Inc. Heterocyclic compounds as RSV inhibitors
US11505558B1 (en) 2019-10-04 2022-11-22 Enanta Pharmaceuticals, Inc. Antiviral heterocyclic compounds
UY39032A (es) 2020-01-24 2021-07-30 Enanta Pharm Inc Compuestos heterocíclicos como agentes antivirales
US11534439B2 (en) 2020-07-07 2022-12-27 Enanta Pharmaceuticals, Inc. Dihydroquinoxaline and dihydropyridopyrazine derivatives as RSV inhibitors
US11945824B2 (en) 2020-10-19 2024-04-02 Enanta Pharmaceuticals, Inc. Heterocyclic compounds as anti-viral agents

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3371085A (en) * 1959-12-10 1968-02-27 Hoffmann La Roche 5-aryl-3h-1,4-benzodiazepin-2(1h)-ones
JPS4426302Y1 (fr) * 1966-04-22 1969-11-05

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0167919A2 (fr) * 1984-06-26 1986-01-15 Merck & Co. Inc. Dérivés de benzodiazépine et compositions pharmaceutiques les contenant
EP0167919A3 (en) * 1984-06-26 1986-11-05 Merck & Co. Inc. Benzodiazepine derivatives and pharmaceutical compositions containing them
EP0284256B1 (fr) * 1987-03-16 1994-06-01 Merck & Co. Inc. Analogues de la benzodiazépine

Also Published As

Publication number Publication date
NL7410256A (nl) 1975-02-03
ZA744635B (en) 1975-08-27
GB1481219A (en) 1977-07-27
DK393274A (fr) 1975-04-01
DE2436744A1 (de) 1975-02-27
DK138798C (fr) 1979-04-09
SE7409708L (fr) 1975-01-31
CA1021778A (fr) 1977-11-29
AT337192B (de) 1977-06-10
SU528872A3 (ru) 1976-09-15
BE818047A (fr) 1974-11-18
NO137897C (no) 1978-05-16
ES428675A1 (es) 1976-09-01
AR202224A1 (es) 1975-05-23
ATA567674A (de) 1976-10-15
CH573928A5 (fr) 1976-03-31
FI227474A (fr) 1975-01-31
FR2239464B1 (fr) 1978-04-14
DK138798B (da) 1978-10-30
IL45289A0 (en) 1974-10-22
US4010153A (en) 1977-03-01
HU169180B (fr) 1976-10-28
NO137897B (no) 1978-02-06
IE39904B1 (en) 1979-01-31
IL45289A (en) 1979-12-30
JPS5041886A (fr) 1975-04-16
SE7510823L (sv) 1975-09-26
NO742739L (fr) 1975-02-24
IE39904L (en) 1975-01-30

Similar Documents

Publication Publication Date Title
DK138798C (fr)
AU476696B2 (fr)
HU166787B (fr)
AR197627A1 (fr)
AU480004B2 (fr)
AR196382A1 (fr)
AR195311A1 (fr)
AR193950A1 (fr)
JPS5075118A (fr)
AR196212Q (fr)
CH564641A5 (fr)
BG25647A3 (fr)
BG20934A1 (fr)
BG18532A1 (fr)
BG19495A1 (fr)
CH564639A5 (fr)
BG20169A1 (fr)
BG20918A1 (fr)
AU479521A (fr)
AU479504A (fr)
AU479496A (fr)
CH567718A5 (fr)
AU479539A (fr)
AU479522A (fr)
CH564482A5 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse